Novavax Inc. Stock Rises 20.1%, Outperforms Peers
Dow Jones2026/10/05 20:33This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Novavax Inc. rocketed 20.1% to $12.56 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 27,477.31 and the Dow Jones Industrial Average rising 0.2% to 51,267.90. The stock's rise snapped a three-day losing streak. Novavax Inc. hit a new 52-week high, surpassing its previous peak of $11.97, which the company achieved on February 26th. The stock outperformed some of its peers, as Johnson & Johnson fell 1.2% to $252.93, Pfizer Inc. fell 1.4% to $27.41, and Merck & Co. Inc. fell 3.30% to $139.54. Trading volume totaled 28.4 million, compared to the 50-day average of 4.8 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 05, 2026 16:33 ET (20:33 GMT)
This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. rocketed 20.1% to $12.56 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 27,477.31 and the Dow Jones Industrial Average rising 0.2% to 51,267.90.
The stock's rise snapped a three-day losing streak.
Novavax Inc. hit a new 52-week high, surpassing its previous peak of $11.97, which the company achieved on February 26th.
The stock outperformed some of its peers, as Johnson & Johnson fell 1.2% to $252.93, Pfizer Inc. fell 1.4% to $27.41, and Merck & Co. Inc. fell 3.30% to $139.54.
Trading volume totaled 28.4 million, compared to the 50-day average of 4.8 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 05, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
ICE brings futures trading to London’s $190 billion-a-day physical gold market
Precia reports 5,733,040 issued shares, 8,350,574 exercisable voting rights as of Aug. 31, 2026
Precia disclosed 5,733,040 issued shares as of Aug. 31, 2026. Theoretical voting rights totaled 8,677,204. Exercisable voting rights stood at 8,350,574, reflecting 326,630 treasury shares without voting rights. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Precia SA published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.
Asia FX: Tech-linked FX could outperform against US Dollar - MUFG
Sumitomo Metal expects global nickel market to stay in surplus in 2027
Crypto prices
More
